Ventricular assist devices in heart failure: How to support the heart but prevent atrophy?

Physiological Research

Volumn 63, Issue 2, 2014, Pages 147-156

  Pokorny M ^a,b   Cervenka L ^a,b   Netuka, I ^a,c   Pirk, J ^a   Konarik M ^a   Maly J ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atrophy; Cardiac; Clenbuterol; Experimental models; Heart; Heterotopic heart transplantation; Mechanical unloading; Ventricular assist devices

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL;

ANIMAL; ATROPHY; HEART ASSIST DEVICE; HEART FAILURE; HUMAN; PATHOLOGY;

ADRENERGIC BETA-AGONISTS; ANIMALS; ATROPHY; CLENBUTEROL; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS;

EID: 84899951926     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. ABOTT CP, LINDSEY ES, CREECH O, DEWITT CW: A technique for heart transplantation in the rat. Arch Surg 89: 645-652, 1964.
2. AHMET I, KRAWCZYK M, HELLER P, MOON C, LAKATTA EG, TALAN MI: Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy. Circulation 110: 1083-1090, 2004.
3. BASKIN KB, TAEGTMEYER H: Taking pressure off the heart: The ins and outs of atrophic remodelling. Cardiovasc Res 90: 243-250, 2011.
4. BIRKS EJ, TANSLEY PD, HARDY J, GEORGE RS, BOWLES CHT, BURKE M, BANNER NR, KHAGHANI A, YACOUB MH: Left ventricular assist device and drug therapy for the reversal of heart failure. New Engl J Med 355: 1873-1884, 2006.
5. BIRKS EJ, GEORGE RS, HEDGER M, BAHRAMI T, WILTON P, BOWLES CHT, WEBB C, BOUGARD R, AMRANI R, YACOUB MH, DREYFUS G, KHAGHANI A: Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: A prospective study. Circulation 123: 381-390, 2011.
6. BURNISTON JG, TAN LB, GOLDSPINK DF: Beta2-adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle. J Appl Physiol 98: 1379-1386, 2005.
7. BUTLER CR, JUGDUTT BI: The paradox of left ventricular device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly. Heart Fail Rev 17: 615-633, 2012.
8. CAO DJ, JIANG N, BLAGG A, JOHNSTONE JL, GONDALIA R, OH M, LUO X, YANG KC, SHELTON JM, ROTHERMEL BA, GILLETTE TG, DORN GW, HILL JA: Mechanical unloading activates FoxO3 to trigger Bnip3-dependent cardiomyocyte atrophy. J Am Heart Assoc 2: e000016, 2013.
9. CHOO JJ, HORAN MA, LITTLE RA: Anabolic effects on skeletal muscle are mediated by beta2-adrenoceptor activation. Am J Physiol 263: E50-E56, 1992.
10. COHN JN, FERRARI R, SHARPE N: Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 35: 569-582, 2000.
11. CORRY RJ, WINN HJ, RUSSEL PS: Heart transplantation in congenic strains of mice. Transplant Proc 5: 733-735, 1973.
12. DANDEL M, WENG Y, SINIAWSKI H, STEPANENKO A, KRABATSCH T, POTAPOV E, LEHMKUHL HB, KNOSALLA C, HETZER R: Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices. Eur Heart J 32: 1148-1160, 2011.
13. DEBAKEY ME: The Odyssey of the artificial heart. Artif Organs 24: 405-411, 2000.
14. DRAKOS SG, TERROVITIS JV, ANASTASIOU-NANA MI, NANAS JN: Reverse remodeling during long-term mechanical unloading of the left ventricle. J Mol Cell Cardiol 43: 231-242, 2007.
15. DRAKOS SG, KFOURY AG, HAMMOND EH, REID BB, REVELO MP, RASMUSSON BY, WHITEHEAD KJ, SALAMA ME, SELZMAN CH, STEHLIK J, CLAYSON SE, BRISTOW MR, RENLUND DG, LI DY: Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. J Am Coll Cardiol 56: 382-391, 2010.
16. DRAKOS SG, KHOURY AG, SELZMAN CH, VERMA DR, NANAS JN, LI DY, STEHLIK J: Left ventricular assist device unloading effects on myocardial structure and function: Current status of the field and call for action. Curr Opin Cardiol 26: 245-255, 2011a.
17. DRAKOS SG, TERROVITIS JV, NANAS JN, CHARITOS EI, NTALIAMIS AS, MALLIARAS KG, DIAKOS N, KOUDOUMAS D, THEODOROPOULOS S, YACOUB MH, ANASTASIOU-NANA MI: Reverse electrophysiologic remodeling after cardiac mechanical unloading for end-stage nonischemic cardiomyopathy. Ann Thorac Surg 91: 764-769, 2011b.
18. DRAKOS SG, WEVER-PINZON O, SELZMAN CH, GILBERT EM, ALHARETHI R, REID BB, SAIDI A, DIAKOS NA, STOKER S, DAVIS ES, MOVSESIAN M, LI DY, STEHLIK J, KFOURY AG: Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure. J Am Col Cardiol 61: 1985-1994, 2013.
19. FELKIN LE, LARA-PEZZI EA, HALL JL, BIRKS EJ, BARTON PJR: Reverse remodelling and recovery from heart failure are associated with complex pattern of gene expression. J Cardiovasc Trans Res 4: 321-331, 2011.
20. FRAZIER OH, BENEDICT CR, RADOVANCEVIC B, BICK RJ, CAPEK P, SPRINGER WE, MACRIS MP, DELGADO R, BUJA LM: Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 62: 675-682, 1996.
21. GALIANANES M, ZHAI X, HEARSE DJ: The effect of load on atrophy, myosin isoform shifts and contractile function: studies in a novel rat heart transplant preparation. J Mol Cell Cardiol 27: 407-417, 1995.
22. GEENEN DL, MALHOTRA A, BUTTRICK PM, SCHEUER J: Ventricular pacing attenuates but does not reverse cardiac atrophy and an isomyosin shift in the rat heart. Am J Physiol 267: H2149-H2154, 1994.
23. HEERDT PM, HOLMES JW, CAI B, BARBONE A, MADIGAN JD, REIKEN S, LEE DL, OZ MC, MARKS AR, BURKHOFF D: Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 102: 2713-2719, 2000.
24. HELLERSTEIN HK, SANTIAGO-STEVENSON D: Atrophy of the heart: a correlative study of eighty-five proved cases. Circulation 1: 93-126, 1950.
25. HON JK, YACOUB MH: Bridge to recovery with the use of left ventricular assist device and clenbuterol. Ann Thorac Surg 75: S36-S41, 2003.
26. IBRAHIM M, NAVARATNARAJAH M, SIEDLECKA U, RAO CH, DIAS P, MOSHOV AV, GORELIK J, YACOUB MH, TERRACCIANO CM: Mechanical unloading reverses transverse tubule remodelling and normalizes local calcium-induced calcium release in a rodent model of heart failure. Eur J Heart Fail 14: 571-580, 2012.
27. IBRAHIM M, NAVARATNARAJAH M, KUKADIA P, RAO CH, SIEDLECKA U, CARTLEDGE JE, SOPPA GK, VAN DOORN C, YACOUB MH, TERRACCIANO CM: Heterotopic abdominal heart transplantation in rats for functional studies of ventricular unloading. J Surg Res 179: E31-E39, 2013.
28. KINOSHITA M, TAKANO H, TAENAKA Y, MORI H, TAKAICHI S, NODA H, TATSUMI E, YAGURA A, SEKII H, AKATSU T: Cardiac disuse atrophy during LVAD pumping. ASAIO Trans 34: 208-212, 1988.
29. KINOSHITA M, TAKANO H, TAKAICHI S, TAENAKA Y, NAKATANI T: Influence of prolonged ventricular assistance on myocardial histopathology in intact heart. Ann Thor Surg 61: 640-645, 1996.
30. KLEIN I, HONG C, SCHREIBER SS: Cardiac atrophy in the heterotopically transplanted rat heart: in vitro protein synthesis. J Mol Cell Cardiol 22: 461-468, 1990.
31. KLEIN I, HONG C, SCHREIBER SS: Isovolumic loading prevents atrophy of the heterotopically transplanted rat heart. Circ Res 69: 1421-1425, 1991.
32. KLEIN I, SAMAREL AM, WELIKSON R, HONG C: Heterotopic cardiac transplantation decreases the capacity for rat myocardial protein synthesis. Circ Res 68: 1100-1107, 1991.
33. KLOTZ S, JAN DANSER AH, BURHOFF D: Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process. Prog Biophys Mol Bio 97: 479-496, 2008.
34. KORECKY B, MASIKA M: Direct effect of increased hemodynamic load on cardiac mass. Circ Res 68: 1174-1178, 1991.
35. MANN DL, BRISTOL MR: Mechanisms and models in heart failure: The biomechanics model and beyond. Circulation 111: 2837-2849, 2005.
36. MANN DL, BARGER PM, BURKHOFF D: Myocardial recovery and the failing heart. J Am Coll Cardiol 60: 2465-2472, 2012.
37. MANN FC, PRIESTLEY JT, MARKOWITZ J, YATER WM: Transplantation of the intact mammalian heart. Arch Surg 26: 219-224, 1933.
38. MAYBAUM S, MANCINI D, XYDAS S, STARLING RC, AARONSON K, PAGANI FD, MILLER LW, MARGULIES K, MCREE S, FRAZIER OH, TORRE-AMIONE G: Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD working group. Circulation 115: 2497-2505, 2007.
39. MIZUNO T, WEISEL RD, LI RK: Reloading the heart: a new animal model of left ventricular assist device removal. J Thorac Cardiovasc Surg 130: 99-106, 2005.
40. MURANAKA H, MARUI A, TSUKASHITA M, WANG J, NAKANO J, IKEDA T, SAKATA R: Prolonged mechanical unloading preserves myocardial contractility but impairs relaxation in rat heart of dilated cardiomyopathy accompanied by myocardial stiffness and apoptosis. J Thor Cardiovasc Surg 140: 916-922, 2010.
41. OGLETREE ML, SWEET WE, TALERICO C, KLECKA ME, YOUNG JB, SMERIDA NG, STARLING RC, MORAVEC CS: Duration of left ventricular assist device support: effects on abnormal calcium cycling and functional recovery in the failing human heart. J Heart Lung Transplant 29: 554-561, 2010.
42. ORIYANHAN W, TSUNEYOSHI H, NISHINA T, MATSUOKA S, IKEDA T, KOMEDA M: Determination of optimal duration of mechanical unloading for failing hearts to achieve bridge to recovery in a rat heterotopic heart transplantation model. J Heart Lung Transplant 26: 16-23, 2007.
43. PERHONEN MA, FRANCO F, LANE LD, BUCKEY JC, BLOMQVIST CG, ZERWEKH JE, PESHOCK RM, WEATHERALL PT, LEVINE BD: Cardiac atrophy after bed rest and spaceflight. J Appl Physiol 91: 645-653, 2001.
44. PETROU M, WYNNE DG, BOHELER KR, YACOUB MH: Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes. Circulation 92: 483-489, 1995.
45. RAKUSAN K, HERON MI, KOLAR F, KORECKY B: Transplantation-induced atrophy of normal and hypertrophic rat hearts: effect on cardiac myocytes and capillaries. J Mol Cell Cardiol 29: 1045-1054, 1997.
46. RAZEGHI P, SHARMA S, YING J, LI Y, STEPKOWSKI S, REID MB, TAEGTMEYER H: Atrophic remodeling of the heart in vivo simultaneously activates pathways of protein synthesis and degradation. Circulation 108: 2536-2541, 2003.
47. RAZEGHI P, VOLPINI KC, WANG M, YOUKER KA, STEPKOWSKI S, TAEGTMEYER H: Mechanical unloading of the heart activates the calpain system. J Mol Cell Cardiol 42: 449-452, 2007.
48. RODRIGUE-WAY A, BURHOFF D, GEESAMAN BJ, GOLDEN BS, XU J, POLLMAN J, DONOGHUE M, JEYSEELAN R, HOUSER S, BREITBART RE, MARKS A, ACTON S: Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support. J Heart Lung Transplant 24: 73-80, 2005.
49. RUZZA A, VESPIGIANI R, CZER LS, DE ROBERTIS M, WU GN, TRENTO A: Heterotopic heart transplantation in rats: improved anesthetic and surgical technique. Transplant Proc 42: 3828-3832, 2010.
50. SCHENA S, KURIMOTO Y, FUKADA J, TACK I, RUIZ P, PANG M, STRIKER LJ, AITOUCHE A, PHAM SM: Effects of ventricular unloading on apoptosis and atrophy of cardiac myocytes. J Surg Res 120: 119-126, 2004.
51. SOPPA GK, LEE J, STAGG MA, FELKIN LE, BARTON PJ, SIEDLECKA U, YOUSSEF S, YACOUB MH, TERRACCIANO CM: Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unlading in murine heart failure. Cardiovasc Res 77: 695-706, 2008.
52. SOPPA GKR, BARTON PJR, TERRACCIANO CMN, YACOUB MH: Left ventricular assist device-induced molecular changes in the failing myocardium. Curr Opin Cardiol 23: 206-218, 2008.
53. TERRACCIANO CMN, HARDING SE, ADAMSON S, KOBAN M, TANSLEY P, BIRKS EJ, BARTON PJR, YACOUB MH: Changes in sarcolemal Ca entry and sarcoplasmatic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy. Eur Heart J 24: 1329-1339, 2003.
54. TERRACCIANO CMN, HARDY J, BIRKS EJ, KHAGHANI A, BANNER NR, YACOUB MH: Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation 109: 2263-2265, 2004.
55. THOMPSON EW, MARINO TA, UBOH E, KENT RL, COOPER G: Atropy reversal and cardiocyte redifferentiation in reloaded cat myocardium. Circ Res 54: 367-377, 1984.
56. TSUNEYOSHI H, ORIYANHAN W, KANEMITSU H, SHIINA R, NISHINA T, MATSUOKA S, IKEDA T, KOMEDA M: Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading? Circulation 112: I51-I56, 2005.
57. WILLIS MS, ROJAS M, LI L, SELZMAN CH, TANG R, STANSFIELD WE, RODRIGUEZ JE, GLASS DJ, PATTERSON C: Muscle ring finger 1 mediates cardiac atrophy in vivo. Am J Physiol Heart Circ Physiol 296: 997-1006, 2009.
58. WONG K, BOHELER KR, BISHOP J, PERTOU M: Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features. Cardiovasc Res 37: 115-122, 1998.
59. XYDAS S, KHERANI AR, CHANG JS, KLOTZ S, HAY I, MUTRIE CJ, MOSS GW, GU A SCHULMAN AR, GAO D, HU D, WU EX, WEI C, OZ MC, WANG J: Beta2-adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy. J Phar Exp Ther 317: 553-561, 2006.
60. YACOUB MH: A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur Heart J 22: 534-540, 2001.